Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Permutt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|November 25, 2018
Defining Treatment Effects: A Primer for NonstatisticiansThomas Permutt
Statistics in Medicine|December 6, 2016
Comments on 'Estimands in clinical trials - broadening the perspective'Thomas Permutt
Statistics in Medicine|December 19, 2015
A taxonomy of estimands for regulatory clinical trials with discontinuationsThomas Permutt
Statistics in Medicine|November 17, 2015
Sensitivity analysis for missing data in regulatory submissionsThomas Permutt
Journal of Biopharmaceutical Statistics|August 19, 2003
Probability models and computational models for ANOVA in multicenter clinical trialsThomas Permutt
Clinical Trials (London, England)|February 16, 2019
Defining treatment effects: A regulatory perspectiveThomas Permutt
Statistics in Medicine|November 8, 2017
Author's reply to comments on "A taxonomy of estimands for regulatory clinical trials with discontinuations"Thomas Permutt
Pharmaceutical Statistics|August 16, 2016
Trimmed means for symptom trials with dropoutsThomas Permutt, Feng Li
Statistics in Medicine|December 19, 2015
A regulatory perspective on missing data in the aftermath of the NRC reportLisa M LaVange, Thomas Permutt
Pharmaceutical Statistics|June 21, 2017
Missing data in clinical trials: control-based mean imputation and sensitivity analysisDevan V Mehrotra, Fang Liu, Thomas Permutt
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|November 25, 2018
Defining Treatment Effects: A Primer for NonstatisticiansThomas Permutt
Statistics in Medicine|December 6, 2016
Comments on 'Estimands in clinical trials - broadening the perspective'Thomas Permutt
Statistics in Medicine|December 19, 2015
A taxonomy of estimands for regulatory clinical trials with discontinuationsThomas Permutt
Statistics in Medicine|November 17, 2015
Sensitivity analysis for missing data in regulatory submissionsThomas Permutt
Journal of Biopharmaceutical Statistics|August 19, 2003
Probability models and computational models for ANOVA in multicenter clinical trialsThomas Permutt
Clinical Trials (London, England)|February 16, 2019
Defining treatment effects: A regulatory perspectiveThomas Permutt
Statistics in Medicine|November 8, 2017
Author's reply to comments on "A taxonomy of estimands for regulatory clinical trials with discontinuations"Thomas Permutt
Pharmaceutical Statistics|August 16, 2016
Trimmed means for symptom trials with dropoutsThomas Permutt, Feng Li
Statistics in Medicine|December 19, 2015
A regulatory perspective on missing data in the aftermath of the NRC reportLisa M LaVange, Thomas Permutt
Pharmaceutical Statistics|June 21, 2017
Missing data in clinical trials: control-based mean imputation and sensitivity analysisDevan V Mehrotra, Fang Liu, Thomas Permutt
Pageof 2